Dimensional Fund Advisors
ELDN icon

Dimensional Fund Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History

Dimensional Fund Advisors’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Sell
67,081
-48,601
-42% -$114K ﹤0.01% 3067
2025
Q4 		$175K Sell
115,682
-19,079
-14% -$45.4K ﹤0.01% 3102
2025
Q3 		$349K Sell
134,761
-1,695
-1% -$4.96K ﹤0.01% 3046
2025
Q2 		$370K Buy
136,456
+20,281
+17% +$60.8K ﹤0.01% 3042
2025
Q1 		$394K Buy
116,175
+93,142
+404% +$383K ﹤0.01% 3029
2024
Q4 		$94.9K Sell
23,033
-11,190
-33% -$44.1K ﹤0.01% 3246
2024
Q3 		$85.2K Buy
34,223
+3,990
+13% +$10.7K ﹤0.01% 3252
2024
Q2 		$79.8K Buy
+30,233
New +$72.2K ﹤0.01% 3273
2023
Q2 		– Sell
-17,954
Closed -$42.4K – 3492
2023
Q1 		$42.4K Hold
17,954
– – ﹤0.01% 3396
2022
Q4 		$42 Buy
17,954
+4
+0% +$10 ﹤0.01% 3407
2022
Q3 		$50K Buy
+17,950
New +$57.2K ﹤0.01% 3404

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Dimensional Fund Advisors's ELDN Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Eledon Pharmaceuticals (ELDN) stake by 42% in Q1 2026, selling an estimated $114K and leaving 67,081 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #3067.

Dimensional Fund Advisors first reported a position in ELDN in Q3 2022 and has held it in 11 quarters since. The position peaked at $394K in Q1 2025. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • Dimensional Fund Advisors held 67,081 shares of Eledon Pharmaceuticals worth $204K as of Q1 2026.
  • Dimensional Fund Advisors sold 48,601 Eledon Pharmaceuticals shares in Q1 2026, an estimated $114K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3067 holding.
  • Dimensional Fund Advisors first reported a position in Eledon Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
  • Dimensional Fund Advisors's Eledon Pharmaceuticals position peaked at $394K in Q1 2025.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.